Meet Corealis Pharma at the M-CERSI Biorelevant Dissolution Workshop
Join us in Rockville for discussions on dissolution science, risk assessment, and clinical relevance.
Corealis Pharma is attending the M-CERSI workshop, The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance, taking place April 30 to May 1, 2026. The two-day public workshop is sponsored by the University of Maryland Center for Excellence in Regulatory Science and Innovation and the FDA.
Attending the M-CERSI workshop in Rockville?
Connect with David Kwajewski to discuss formulation development, dissolution strategy, and oral solid dose innovation.
Meet Us There
Stop by to connect with our team and discover how Corealis turns complex molecules into clinical success stories.
